[go: up one dir, main page]

SG11201607588WA - Methods of detecting multi-drug resistant organisms - Google Patents

Methods of detecting multi-drug resistant organisms

Info

Publication number
SG11201607588WA
SG11201607588WA SG11201607588WA SG11201607588WA SG11201607588WA SG 11201607588W A SG11201607588W A SG 11201607588WA SG 11201607588W A SG11201607588W A SG 11201607588WA SG 11201607588W A SG11201607588W A SG 11201607588WA SG 11201607588W A SG11201607588W A SG 11201607588WA
Authority
SG
Singapore
Prior art keywords
methods
drug resistant
resistant organisms
detecting multi
detecting
Prior art date
Application number
SG11201607588WA
Other languages
English (en)
Inventor
George Terrance Walker
Tony Rockweiler
Alex Saeed
Vadim Sapiro
Rossio Kersey
Original Assignee
Opgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Opgen Inc filed Critical Opgen Inc
Publication of SG11201607588WA publication Critical patent/SG11201607588WA/en

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16ZINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
    • G16Z99/00Subject matter not provided for in other main groups of this subclass
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11201607588WA 2014-03-13 2015-03-13 Methods of detecting multi-drug resistant organisms SG11201607588WA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461952795P 2014-03-13 2014-03-13
US201562116860P 2015-02-16 2015-02-16
PCT/US2015/020590 WO2015138991A2 (fr) 2014-03-13 2015-03-13 Méthodes de détection d'organismes multi-résistants aux médicaments

Publications (1)

Publication Number Publication Date
SG11201607588WA true SG11201607588WA (en) 2016-10-28

Family

ID=52727473

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201607588WA SG11201607588WA (en) 2014-03-13 2015-03-13 Methods of detecting multi-drug resistant organisms

Country Status (9)

Country Link
US (2) US20150259729A1 (fr)
EP (1) EP3117010A2 (fr)
KR (1) KR20170026322A (fr)
CN (1) CN106574295A (fr)
AU (1) AU2015229077A1 (fr)
CA (1) CA2942405A1 (fr)
IL (1) IL247770A0 (fr)
SG (1) SG11201607588WA (fr)
WO (1) WO2015138991A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3117010A2 (fr) 2014-03-13 2017-01-18 Opgen, Inc. Méthodes de détection d'organismes multi-résistants aux médicaments
WO2015184017A1 (fr) 2014-05-27 2015-12-03 Opgen, Inc. Systèmes, appareil et procédés pour générer et analyser des profils de résistome
EP3426800A1 (fr) 2016-03-07 2019-01-16 Opgen, Inc. Procédés et systèmes pour déterminer une sensibilité aux antibiotiques
US10629291B2 (en) * 2016-03-10 2020-04-21 Koninklijke Philips N.V. Antibiotic resistance causation identification
WO2017187178A1 (fr) * 2016-04-27 2017-11-02 The Secretary Of State For Health Procédé pour la détection de bactéries produisant de la carbapénémase
US11708614B2 (en) 2016-06-15 2023-07-25 Streck Llc Assays and methods for determining microbial resistance
CA3042525A1 (fr) * 2016-11-01 2018-05-11 Synthetic Biologics, Inc. Methodes et compositions pour attenuer la resistance aux antibiotiques
CA3049582A1 (fr) * 2017-01-08 2018-07-12 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Systemes et procedes d'utilisation d'apprentissage supervise pour prevoir une de bacteriemie specifique d'un sujet
CN107475422B (zh) * 2017-09-08 2020-06-02 中国人民解放军总医院 用于肺炎致病菌耐药基因快速检测的试剂盒
PH12021552983A1 (en) * 2019-05-28 2022-11-07 Fonterra Cooperative Group Ltd Process for source attribution
US20250270657A1 (en) * 2019-05-31 2025-08-28 Streck, Inc. Detection of Antibiotic Resistance Genes
CN110438247B (zh) * 2019-08-20 2021-02-05 中国医学科学院北京协和医院 用于检测大肠埃希菌和肺炎克雷伯菌及其毒性和耐药性的核酸试剂、试剂盒、系统及方法
CN110554109A (zh) * 2019-08-29 2019-12-10 同济大学 一种抗生素菌渣的安全性评估方法
CN110669853A (zh) * 2019-11-04 2020-01-10 深圳市人民医院 一种检测非粘液型肺炎克雷伯菌毒力的方法
EP3988676A1 (fr) * 2020-10-23 2022-04-27 Universität Heidelberg Pcr multiplex pour la détection de gènes de carbapénèmase
US20250011882A1 (en) * 2021-11-22 2025-01-09 Roche Molecular Systems, Inc. Compositions and Methods for Detecting vanA and/or vanB Genes Associated with Multidrug Resistance
TWM642197U (zh) * 2021-12-06 2023-06-11 衛生福利部疾病管制署 藉由固相吸附富集微生物核酸以鑑定微生物及/或抗藥基因的檢測系統
CN115798574B (zh) * 2023-02-06 2023-06-02 中国医学科学院北京协和医院 一种预测克雷伯氏菌属对美罗培南敏感性的系统及方法
CN115862730B (zh) * 2023-02-06 2023-06-02 中国医学科学院北京协和医院 一种预测克雷伯氏菌属对头孢西丁敏感性的系统及方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100868765B1 (ko) 2006-09-29 2008-11-17 삼성전자주식회사 항생제 내성 박테리아의 표적 서열을 증폭시킬 수 있는프라이머 세트, 박테리아의 표적 서열에 특이적으로혼성화하는 프로브 세트, 상기 프로브 세트가 고정화되어있는 마이크로어레이 및 상기 프로브 세트를 이용하여박테리아의 존재를 검출하는 방법
ES2327703B1 (es) * 2008-04-30 2010-07-07 Universidad Del Pais Vasco Metodos y reactivos para la deteccion de salmonella sp.
WO2010039763A2 (fr) * 2008-10-03 2010-04-08 Ibis Biosciences, Inc. Compositions à utiliser pour l'identification de bactéries résistant aux antibiotiques
FI20095544A0 (fi) * 2009-05-15 2009-05-15 Juha Kirveskari Menetelmä ja kitti antibioottiresistenttien bakteerien tunnistusta varten
US20130065790A1 (en) * 2010-05-05 2013-03-14 Check-Points Holding B.V. Assays, compositions and methods for detecting drug resistant micro-organisms
US20130183679A1 (en) 2010-09-10 2013-07-18 Marie-Cecile Ploy Method for detecting the presence of bacterial strains resistant to antibiotics in a biological sample
IN2014MN01780A (fr) * 2012-02-09 2015-07-03 Memed Diagnostics Ltd
WO2013163210A1 (fr) * 2012-04-23 2013-10-31 Philip Alexander Rolfe Procédé et système pour la détection d'un organisme
CN102899414A (zh) 2012-10-10 2013-01-30 南方医科大学 超级细菌ndm和kpc基因双重荧光定量pcr检测方法及其试剂盒
EP3099813B1 (fr) 2014-01-30 2019-06-05 Ares Genetics GmbH Test de résistance génétique
EP3117010A2 (fr) 2014-03-13 2017-01-18 Opgen, Inc. Méthodes de détection d'organismes multi-résistants aux médicaments
WO2015184017A1 (fr) 2014-05-27 2015-12-03 Opgen, Inc. Systèmes, appareil et procédés pour générer et analyser des profils de résistome
EP3426800A1 (fr) 2016-03-07 2019-01-16 Opgen, Inc. Procédés et systèmes pour déterminer une sensibilité aux antibiotiques

Also Published As

Publication number Publication date
US20180342310A1 (en) 2018-11-29
KR20170026322A (ko) 2017-03-08
WO2015138991A3 (fr) 2015-11-12
CN106574295A (zh) 2017-04-19
AU2015229077A1 (en) 2016-09-29
WO2015138991A2 (fr) 2015-09-17
US20150259729A1 (en) 2015-09-17
EP3117010A2 (fr) 2017-01-18
IL247770A0 (en) 2016-11-30
CA2942405A1 (fr) 2015-09-17
US10876162B2 (en) 2020-12-29

Similar Documents

Publication Publication Date Title
IL247770A0 (en) Methods for detecting organisms resistant to multiple drugs
GB2522781B (en) Mark detecting method
GB2516131B (en) Proximity detection
EP3191869A4 (fr) Discrétisation de zone de détection
GB201417162D0 (en) Inspection appartus
GB201412977D0 (en) Single nucleotide detection method
GB2533284B (en) Performing object detection
GB201408100D0 (en) Detection method
GB201410646D0 (en) Methods of increasing sequencing accuracy
GB201414745D0 (en) Exonucleases
GB201415761D0 (en) Methods for detection of Nucleotide modification
SG11201700274XA (en) Electrochemical detection of microorganisms
GB201412316D0 (en) Detecting the absence of micro-organisms
GB201403820D0 (en) Assay
HUE042120T2 (hu) Kodek inverzió detektálás
GB201405203D0 (en) Detecting apparatus
GB201405235D0 (en) Improved plumbing apparatus
BR112017007401A2 (pt) métodos de detecção específicos
SG11201610430QA (en) Growth-independent detection of cells
GB2533151B (en) Improved probe
GB201416459D0 (en) Detection method
GB201415864D0 (en) Methods of detecting of multidrug resistant bacteria
GB201419330D0 (en) Detection method
GB201411568D0 (en) Detection
IL247270A0 (en) A method for detecting cancer